KGAUF yields 1000.00% · PFE yields 6.13%● Live data
📍 KGAUF pulled ahead of the other in Year 1
Combined, KGAUF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KGAUF + PFE for your $10,000?
Kongsberg Automotive ASA develops, manufactures, and sells products to the automotive industry worldwide. The company operates through Powertrain & Chassis and Specialty Products segments. The Powertrain & Chassis segment designs, manufactures, and tests custom powertrain and chassis solutions, including gear shifters for automatic and manual transmissions, shift cables and towers, and vehicle dynamics products for cabins and axles, as well as gear and clutch control systems comprise of actuators. The Specialty Products segment offers fluid handling systems; couplings systems for compressed-air circuits in heavy-duty vehicles; and operator control systems for power sports construction, agriculture, outdoor power equipment, and power electronics products. It serves OEMs and Tier 1 suppliers in the automotive, commercial vehicle, and off-highway markets. The company was formerly known as Kongsberg Automotive Holding ASA and changed its name to Kongsberg Automotive ASA in August 2014. Kongsberg Automotive ASA was founded in 1957 and is based in Kongsberg, Norway.
Full KGAUF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.